相关实验视频
Updated: May 1, 2026
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.2K
扩展性心肌病:从基因和分子到潜在的治疗方法
Xiumei Wang1,2, Zekun Lang2, Zeyi Yan2
1Department of Anesthesiology and Operating Theater, The First Hospital of Lanzhou University, Lanzhou, 730000, The People's Republic of China.
Molecular and cellular biochemistry
|March 29, 2025
概括
扩张性心肌病,心脏病导致心室膨胀和心力衰竭,通常是遗传的. 对TTN,LMNA和MYH7等基因的研究为这种严重疾病提供了新的治疗点.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 扩张性心肌病 (DCM) 的特点是心室扩大和缩功能受损,往往导致充血性心力衰竭.
- 在DCM中,家族遗传是重要的,在约50%的受影响个体中发现了致病基因突变.
- 涉及DCM的关键基因包括TTN,LMNA和MYH7,目前正在进行研究,探索它们的作用.
研究的目的:
- 为了突出扩张性心肌病的遗传基础.
- 强调基因检测在诊断中的重要性.
- 讨论DCM目前和新兴的治疗策略.
主要方法:
- 对扩张性心肌病遗传学和病变发生现有文献的综述.
- 分析与DCM相关的常见遗传突变.
- 探索包括遗传检测在内的诊断方法.
- 目前治疗方法和新型临床前研究的概述.
主要成果:
- 基因突变,特别是TTN,LMNA和MYH7中的基因突变,是DCM的主要贡献者.
- 心肌炎症,代谢异常和心肌细胞亡在DCM病变发生过程中至关重要.
- 基因检测对于DCM的准确和及时的临床诊断越来越重要.
- 心脏移植仍然是主要的治疗方法,但由于供体稀缺,需要替代疗法.
结论:
- 了解DCM的遗传基础为未来的治疗提供了关键的目标.
- 结合临床评估,成像和遗传检测的综合诊断方法至关重要.
- 包括干细胞治疗在内的新型治疗途径正在调查中,以解决DCM管理中的未满足需求.
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:25Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753